Pharmacokinetic

12 drugs in development·7 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(4)

Drug	Company
deupirfenidone	PureTech Health plc (PRTC)
pf614	Ensysce Biosciences Inc. (ENSC)
pf614-mpar	Ensysce Biosciences Inc. (ENSC)
pirfenidone	PureTech Health plc (PRTC)

Phase 1(4)

Drug	Company
deupirfenidone	PureTech Health plc (PRTC)
nafamostat	Ensysce Biosciences Inc. (ENSC)
olverembatinib	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
sulopenem	Iterum Therapeutics plc (ITRM)

Unknown(2)

Drug	Company
Caspofungin	ENANTA PHARMACEUTICALS INC (ENTA)
ltx-03	ACURA PHARMACEUTICALS, INC (ACUR)

Phase 2/Phase 3(2)

Drug	Company
i004	Amphastar Pharmaceuticals, Inc. (AMPH)
novolog	Amphastar Pharmaceuticals, Inc. (AMPH)

BioSniper tracks 12 drugs in development for Pharmacokinetic across 7 companies.

There are 1 clinical trial targeting Pharmacokinetic tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.